Log In
BCIQ
Print this Print this
 

BPN-13661

  Manage Alerts
Collapse Summary General Information
Company Oricula Therapeutics LLC
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationHearing loss
Indication DetailsPrevent hearing loss in patients treated with aminoglycoside antibiotics
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today